Business
COVID-19 vaccine from China’s Sinovac 91.25 per cent effective, Turkey says after trial involving 7,000 volunteers – ABC News
A COVID-19 vaccine developed by China’s Sinovac Biotech is 91.25 per cent effective, according to interim data from a late-stage trial in Turkey.
A COVID-19 vaccine developed by China’s Sinovac Biotech has been 91.25 per cent effective, according to interim data from a late-stage trial in Turkey, a potentially much better result than reported from a separate trial of the vaccine in Brazil.
Key points:
- The Turkish trials began on September 14 and have included more than 7,000 volunteers
- Common adverse effects caused by the vaccine were fever, mild pain and slight fatigue
- 26 of the 29 people who were infected during the trial were given placebos
…
Continue Reading
-
General22 hours agoTasmanian boy left homeless due to child protection department’s ‘gross negligence’, family member says
-
Business16 hours agoBell Potter names the best ASX tech stocks to buy in FY 2026
-
Business21 hours ago2 excellent ASX ETFs I think have great potential to beat the ASX 200
-
General12 hours agoHuman remains located, police make arrest in search for Sunbury man Joshua Bishop